July 29, 2016 6:07 PM ET

Metals and Mining

Company Overview of Ansell Capital Corp.

Company Overview

As of November 27, 2014, Ansell Capital Corp. was acquired by BriaCell Therapeutics Corp., in a reverse merger transaction. Ansell Capital Corp. Prior To Reverse Merger With BriaCell Therapeutics Corp. acquires, explores, and develops mineral properties. It primarily explores for gold, silver, copper, and other metals. The company holds interests in the Kuyakuz Mountain project located in British Columbia, Canada; and the Charlotte property located in the Yukon Territory, Canada. It also holds an option agreement to acquire a 100% interest in the Dal, the Discovery Creek, and the Etzel properties located in the Yukon Territory, Canada. The company was incorporated in 2006 and is based in Wes...

Bellevue Centre

3rd Floor

235-15th Street

West Vancouver, BC V7T 2X1


Founded in 2006





Key Executives for Ansell Capital Corp.

Ansell Capital Corp. does not have any Key Executives recorded.

Ansell Capital Corp. Key Developments

Ansell Capital Corp. Announces Board Appointments

On November 25, 2014, Ansell Capital Corp. filed a Notice of Alteration with the Registrar of Companies of the Province of British Columbia to change its corporate name from "Ansell Capital Corp." to "BriaCell Therapeutics Corp." The name change followed a 3.25 to 1 share consolidation both of which were approved at the company's Annual General and Special Meeting held on the same date. The name change was approved and the company's proposed nominees, Rahoul Sharan, and new directors, Dr. Charles Wiseman, Dr. Saeid Babei and Isaac B. Maresky were all appointed to the Board.

Ansell Capital Corp. Auditor Raises 'Going Concern' Doubt

Ansell Capital Corp. filed its Annual on Oct 23, 2014 for the period ending Jul 31, 2014. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Ansell Capital Corp., Special/Extraordinary Shareholders Meeting, Nov 25, 2014

Ansell Capital Corp., Special/Extraordinary Shareholders Meeting, Nov 25, 2014., at 10:30 Pacific Standard Time. Location: 217-179 Davie Street. Agenda: To consider and approve a consolidation of the issued and outstanding common shares of Ansell on a 3.25-old for 1- new basis as part of Ansell's proposed acquisition of BriaCell Therapeutics Corp.; to consider and authorize Ansell to acquire all of the issued and outstanding shares of BriaCell Therapeutics Corp. for and in consideration 53,111,568 post-consolidated common shares of Ansell giving rise to a change of business and reverse takeover of Ansell with the share consideration to be issued subject to Value Securities escrow conditions; to authorize Ansell to change its name to "BriaCell Therapeutics Corp.", or such other name as the board of directors of Ansell may determine to be acted upon concurrently with Ansell's acquisition of BriaCell; and to receive the report of the directors, the audited financial statements of Ansell for the period ended July 31, 2014, and the report of the auditors thereon.

Similar Private Companies By Industry

Company Name Region
0796839 B.C. Ltd. Americas
1031216 B.C. Ltd. Americas
13 Mining Titles in Opinaca Americas
1330275 Ontario Ltd. Americas
1343080 Alberta Ltd Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ansell Capital Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.